Balchem Corporation - Common Stock (BCPC)
159.39
-0.89 (-0.56%)
Balchem Corp is a specialty chemical company that focuses on the production of various nutritional and industrial products
The company operates through multiple segments, including nutritional products for human and animal health, as well as specialized products for industrial applications. Balchem is dedicated to innovation and sustainability, providing solutions that enhance the nutritional value of foods, improve animal health and productivity, and support a wide range of industrial processes. With a commitment to research and development, Balchem aims to deliver high-quality products that meet the evolving needs of its customers across diverse markets.
![](https://www.marketbeat.com/logos/articles/med_20241220131235_industrial-chemicals-3-stocks-poised-for-growth-in.jpg)
Chemical manufacturers provide essential ingredients and products for a host of different industries and applications; these firms stand out for the new year.
Via MarketBeat · December 23, 2024
![](https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp)
Exploring BALCHEM CORP (NASDAQBCPC)'s quality characteristics.
Via Chartmill · September 6, 2024
![](https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp)
Reasonable Growth, Debt Levels, and a High ROIC Make BALCHEM CORP (NASDAQBCPC) Appealing to Quality Investors.
Via Chartmill · August 1, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
BCPC stock results show that Balchem beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 26, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
BCPC stock results show that Balchem beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · July 15, 2024
![](https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp)
Why Quality Investors May Find BALCHEM CORP (NASDAQBCPC) Attractive.
Via Chartmill · July 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/07/10/10-Reasons-Michigans-Bird-Flu-Strategy-I_0.jpeg?width=1200&height=800&fit=crop)
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human transmission are low.
Via Benzinga · July 10, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/06/Chicago--Il---July-27--2017-American-Air.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 6, 2024
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Inflation doesn't seem to be moving higher, but its downward trajectory seems to have slowed to a crawl, around 3.2%, which is keeping interest rates higher than anticipated.
Via Talk Markets · March 19, 2024
Markets have remained resilient despite February’s CPI and PPI data coming in hotter than anticipated but it may be time to consider buying several highly ranked basic materials stocks and here are a few to consider.
Via Talk Markets · March 19, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Arbor Realty Trust (NYSEABR) is expected to report quarterly earnings at $0.44 per share on revenue of $97.65 million.
Via Benzinga · February 16, 2024
![](https://investorplace.com/wp-content/uploads/2020/10/healthy-food.jpg)
Food stocks saw a reversal in recent years as markets rejected soy-based alternative meats, but a handful of companies are forging new paths.
Via InvestorPlace · January 7, 2024
![](https://img.freepik.com/free-photo/businessman-hand-rise-up-holding-golden-dollar-coin-currency-exchange-money-transfer-payment-concept-by-3d-render-illustration_616485-129.jpg?size=626&ext=jpg&ga=GA1.1.1846020111.1674633469&semt=sph)
At first glance, October 2023's data for dividend changes looks like an improvement from September 2023. Month-over-month, the number of declared dividend increases rose and the number of dividend decreases fell, which is a positive development.
Via Talk Markets · November 2, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/30/abbvie_-_logo.jpg?width=1200&height=800&fit=crop)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · October 30, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Sanofi (NASDAQSNY) is projected to report quarterly earnings at $2.26 per share on revenue of $12.56 billion.
Via Benzinga · October 27, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Sanofi (NASDAQSNY) is likely to report quarterly earnings at $1.58 per share on revenue of $11.32 billion.
Via Benzinga · July 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_855.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • GrafTech International (NYSEEAF) is likely to report quarterly loss at $0.01 per share on revenue of $123.00 million.
Via Benzinga · April 28, 2023